7775
DAIKEN MEDICAL CO.,LTD.
大研医器
- Industry
- Precision Instruments
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Non-consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
7,861,969
Mar 2022
8,540,443
Mar 2023
9,137,102
Mar 2024
9,750,166
Mar 2025
9,951,701
Operating profit(thousand JPY)
Mar 2021
921,216
Mar 2022
1,150,878
Mar 2023
1,054,459
Mar 2024
1,442,640
Mar 2025
1,512,073
Operating profit margin(%)
Mar 2021
11.72
Mar 2022
13.48
Mar 2023
11.54
Mar 2024
14.8
Mar 2025
15.19
Profit before tax(thousand JPY)
Mar 2021
944,750
Mar 2022
1,151,337
Mar 2023
1,025,025
Mar 2024
1,436,459
Mar 2025
1,508,425
Profit(thousand JPY)
Mar 2021
675,231
Mar 2022
831,056
Mar 2023
712,062
Mar 2024
988,602
Mar 2025
1,097,620
Total assets(thousand JPY)
Mar 2021
10,752,921
Mar 2022
10,920,803
Mar 2023
11,013,404
Mar 2024
11,006,318
Mar 2025
11,181,079
Cash and cash equivalents(thousand JPY)
Mar 2021
2,170,643
Mar 2022
2,518,589
Mar 2023
2,516,212
Mar 2024
2,739,141
Mar 2025
2,995,993
Cash flows from operating activities(thousand JPY)
Mar 2021
609,170
Mar 2022
1,133,623
Mar 2023
989,156
Mar 2024
1,555,500
Mar 2025
1,120,908
Cash flows from investing activities(thousand JPY)
Mar 2021
-311,906
Mar 2022
-196,237
Mar 2023
-210,526
Mar 2024
-168,767
Mar 2025
-168,046
Cash flows from financing activities(thousand JPY)
Mar 2021
-492,021
Mar 2022
-589,439
Mar 2023
-781,007
Mar 2024
-1,163,804
Mar 2025
-696,009
Return on equity(%)
Mar 2021
11
Mar 2022
13.2
Mar 2023
10.9
Mar 2024
14.6
Mar 2025
15.2
Equity ratio(%)
Mar 2021
57.5
Mar 2022
59
Mar 2023
59.7
Mar 2024
63.5
Mar 2025
66.9
Earnings per share(JPY per share)
Mar 2021
23.5
Mar 2022
28.93
Mar 2023
24.79
Mar 2024
34.41
Mar 2025
38.21
Net assets per share(JPY per share)
Mar 2021
215.2
Mar 2022
224.13
Mar 2023
228.91
Mar 2024
243.32
Mar 2025
260.53
Dividend per share(JPY per share)
Mar 2021
20
Mar 2022
20
Mar 2023
20
Mar 2024
21
Mar 2025
23
Payout ratio(%)
Mar 2021
85.11
Mar 2022
69.13
Mar 2023
80.68
Mar 2024
61.03
Mar 2025
60.19
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.